mcrblg-header-image

search

Dr. Blagosklonny – Leading the Way in Reducing Cancer and Anti-Aging


Do you know somebody that has dealt with cancer or are you dealing with it yourself? Cancer is abundant and the amount of research that goes into it is astounding and necessary. Dr. Mikhail Blagosklonny is a Russian scientist that studies cancer for a living. He is a native of St. Petersburg and began his education at the First Pavlov State Medical University of St. Peterburg where he received his Doctorate of Medicine (M.D.) in internal medicine as well as his PhD. in experimental medicine and cardiology. Mikhail Blagosklonny was appointed an associate professor in New York at the New York Medical College and then moved on to senior scientist at the Ordway Research Institute in Albany, New York. In 2009 he was appointed a professor of oncology at Roswell Park Cancer Institute in Buffalo. He stills works for this organization.

Dr. Mikhail Blagosklonny is a prolific writer with over 300 research articles including reviews and book chapters. He is also the editor in chief of Aging, Cell Cycle, and Oncotarget. He has also been an Associate Editor for Cancer Biology & Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, International Journal of Cancer, The American Journal of Pathology and PLOS ONE.

Read more: Distinguished physician-scientist, Dr. Mikhail Blagosklonny, joins Roswell Park Cancer Institute

Dr. Blagosklonny has been an advocate for TOR or target of rapamycin signaling. The thought is that it can slow aging and in the same process slow cancer. He believes that taking this is extremely safe and if not taken is actually dangerous. Mikhail Blagosklonny takes it himself to limit the risk of cancer and for life extension.

Dr. Mikahil Blagosklonny is passionate about his profession and the work he conducts daily. Through his teaching as a professor or through his writing and editing, he provides many paths to share his learning to benefit the public. His views have been substantiated by scientific journals. Rapamycin has continued to climb in its use for reducing cancer and helping to regulate it.

Review publishing of Mikhail Blagosklonny on Impact Journals
Read more about Mikhail Blagosklonny on Nature

Leave a Reply

Your email address will not be published. Required fields are marked *

close
search
avatar

Hi, guest!

settings

menu